Gilead Sciences Inc (GILD)

[LionsTact]

Thanks very much...It's good to see CEO Daniel O’Day collaborating with former employer Roche Holding AG on giving Covid-19 a " Double Tap "... aka " A One-Two Punch "

....(imo) It's a positive step towards full FDA approval as Roche Holding AG likely feels confident with Remdesivir's Phase 3 trials as a 2nd wave hits South Korea and Brazil reaches grim milestones daily.

Roche's Actemra is used to treat inflammatory diseases and to control the cytokine storms associated with certain immuno-oncology treatments.

Gilead’s remdesivir is an antiviral drug. COVID-19 is marked by several unusual symptoms, including blood clotting, cytokine storms and severe pneumonia.